A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension
Clinical trial NCT04503733 · UNKNOWN
Trial details
- NCT number
- NCT04503733
- Sponsor
- Gmax Biopharm LLC.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2022-10-26
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.